i am yasmin vossoughian, i hope amidst overwhelming tragedy in turkey. [speaking non-english] survivors amidst the rubble, people still being found alive days after the earthquake that has killed more than 25,000 people. we are alive on the ground there in just a moment. another object in the sky shut down by the u.s. military, this time over alaska. what we know and just as important don t know about what happened. we are also following some breaking news this hour. nbc news confirming donald trump getting involved and a subpoena issued to his former vice president. have the very latest on that. and then a rally. set to begin in just a couple of hours, in texas. as a judge there gets ready to rule in a case, that could ban the abortion pill everywhere and this country. all of that plaza historic matchup at the super bowl. first time two black quarterbacks will face off. the eagles jalen hurts and the chiefs, patrick mahomes. the next, our talk to doug williams, the fir
Robert Dreicer, MD, MS, MACP, FASCO, acknowledges that there have been substantial developments in therapies and strategies for treating prostate cancer, leading to heightened expectations of breakthroughs in the field.
Benjamin H. Lowentritt, MD, FACS, discusses how results from a real-world retrospective study of responses with second-generation androgen receptor signaling inhibitors in patients with mCSPC could affect the selection and use of next-generation ARSIs in practice, and how this research identifies several other unanswered questions for future investigation.